NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE167388 Query DataSets for GSE167388
Status Public on Jul 06, 2021
Title Suppression of plasmacytoid dendritic cell migration by compounds derived from natural medicines
Organism Mus musculus
Experiment type Expression profiling by array
Summary Background and Aims. Dendritic cells (DCs) play a pivotal role in maintaining immunological homeostasis by orchestrating innate and adaptive immune responses via migration to inflamed sites and the lymph nodes (LNs). Plasmacytoid DCs (pDCs) have been reported to accumulate in the colon of inflammatory bowel disease (IBD) patients and dextran sulfate sodium (DSS)-induced colitis mice. However, the role of pDCs in the progression of colonic inflammation remains unclear. Methods. 80 compounds in natural medicines were searched for inhibitors of pDC migration using bone marrow-derived pDCs (BMpDCs) and conventional DCs (BMcDCs). BALB/c mice were given 3% DSS in the drinking water for 7 days to induce acute colitis. Compounds, which specifically inhibited pDC migration, were administrated into DSS-induced colitis mice. Results. Astragaloside IV (As-IV) and oxymatrine (Oxy) suppressed BMpDC migration but not BMcDC migration. In DSS-induced colitis mice, the number of pDCs was markedly increased in the colonic lamina propria (LP), and the expression of CCL21 was obviously observed in colonic isolated lymphoid follicles (ILFs). As-IV and Oxy reduced symptoms of colitis and the accumulation of pDCs in colonic ILFs but not in the colonic LP. Moreover, in a BMpDC adoptive transfer model, BMpDC migration to colonic ILFs was significantly decreased by treatment with As-IV or Oxy. Conclusion. pDCs accumulated in the colon of DSS-induced colitis mice, and As-IV and Oxy ameliorated DSS-induced colitis by suppressing pDC migration to colonic ILFs. Accordingly, the selective inhibition of pDC migration may be a potential therapeutic approach for treating colonic inflammatory diseases.
 
Overall design To elucidate the mechanism underlying inhibitory effects of Astragaloside IV and Oxymatrine on pDC migration, BMpDCs were generated from bone marrow cells isolated from the femurs and tibias of male BALB/c mice. Mature BMpDCs were treated with Astragaloside IV or Oxymatrine for 12 hours, followed by induction with CCL21 for 1 hour at 37°C.
 
Contributor(s) Yamamoto T, Zhang Y, Hayashi S, Kadowaki M
Citation(s) 34246191
Submission date Feb 24, 2021
Last update date Oct 11, 2021
Contact name Takeshi Yamamoto
E-mail(s) ty@inm.u-toyama.ac.jp
Organization name University of Toyama
Street address 2630 Sugitani
City Toyama
ZIP/Postal code 930-0194
Country Japan
 
Platforms (1)
GPL23038 [Clariom_S_Mouse] Affymetrix Clariom S Assay, Mouse (Includes Pico Assay)
Samples (3)
GSM5104630 Control BMpDCs
GSM5104631 BMpDCs treated with Astragaloside IV
GSM5104632 BMpDCs treated with Oxymatrine
Relations
BioProject PRJNA704551

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE167388_RAW.tar 3.8 Mb (http)(custom) TAR (of CEL, CHP)
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap